Improving care for young people experiencing psychosis

What

Orygen, together with investigators from the University of Melbourne, headspace, Monash University and Deakin University have been funded by the Wellcome Trust to establish the Australian Early Psychosis Collaborative Consortium (AEPCC).

Why

Left untreated, psychotic illnesses can affect young people’s educational outcomes, physical health, employment and relationships. High-quality, evidence-based care helps treat symptoms, and reduces the risk of long-term impacts.

How

AEPCC will provide a framework for streamlining the translation of research into real-world treatment – by establishing a Clinical Trials and Translation Network, a Clinical Quality Registry and a Lived Experience Network.

Researchers

AEPCC will give researchers the opportunity to come together with clinicians and the lived experience community to drive innovative, impactful early psychosis research.

Clinicians

AEPCC will help the early psychosis community better understand client outcomes, and support the continuous improvement of care for young people experiencing psychosis.

Young people

The early psychosis lived experience community of young people, carers and family members will be able to connect, reflect collectively and influence AEPCC’s work.

Improving young lives

AEPCC is innovative, unifying and empowering. We’re bringing together Australia’s early psychosis community like never before – to support each other to drive evidence-based, effective and lasting change that improves the lives of young people.

Apply for free AEPCC membership to be in the know, be involved, be connected and be supported. There’s a membership option for anyone with an interest in, or connection with, early psychosis.

Latest news

First ever early psychosis registry taking shape

We’re excited to draw back the curtain on AEPCC’s Clinical Quality Registry (CQR) and give you a sneak peek of how the platform may look.

September 14, 2022

Collaboration key to shaping early psychosis research agenda

The AEPCC Clinical Trials and Translation Network (CTTN) Establishment Committee has reviewed 10 clinical trials since its inception in August 2021. Of those, one trial

September 7, 2022